Dhanpat Jain, MD, Professor of Pathology and of Medicine (Digestive Diseases), has been named to the Cancer Committee of the College of American Pathologists (CAP), the leading organization of board-certified pathologists that fosters and advocates excellence in the practice of pathology and laboratory medicine worldwide.
The CAP’s Cancer Committee is responsible for writing and periodically updating the cancer synoptic protocols for various cancers. The committee is also in charge of answering any queries pertaining to the staging of various cancers using CAP protocols. In his role, Dr. Jain will be responsible for all GI cancers, including GI biomarkers, and will be part of a three-member panel that includes Lawrence J. Burgart, MD, FCAP, and William Vincent Chopp, MD, FCAP.
Among the committee’s many responsibilities are:
- Providing scientific expertise to CAP on the practice of surgical pathology and the reporting of cancer specimens
- Creating new and reviewing existing reporting checklists case summaries and the supporting protocol material for reporting on cancer specimens from various anatomic sites
- Monitoring new and emerging issues/practices/technologies in surgical and anatomical pathology that may impact CAP members
To qualify for the committee, a candidate must possess a strong interest in promoting the practice of surgical pathology focusing on improving the reporting of cancer specimens. Dr. Jain is a nationally and internationally recognized GI pathologist known for his diagnostic skills, research, and teaching.
Previously, Dr. Jain was a part of the expert panel that updated the hepatobiliary cancer protocols for the CAP. Some of the GI cancer protocols that have recently been updated and are available since this June include appendix, anal canal, stomach, liver and GI cancer biomarkers.
The CAP has for 75 years fostered excellence in laboratories and advanced the practice of pathology and laboratory science. As medicine, technology and pathology continue to evolve, the CAP has been trusted to lead the way to meet new challenges that result in better patient outcomes.